Multiple sclerosis (MS) is the most common neurological disorder among young adults and often results in a handicap. It is an auto-immune disease in which the body attacks its own tissues. The immune attack in MS targets the central nervous system. The lesions are well-localised and are called “plaques”.
7 pertinent questions you might have concerning the vaccination against COVID-19 and your MS treatment. Prof. Dr C. Sindic provides the answers ...
Our mission: to promote MS research and raise awareness among patients, physicians and neurologists, objectively informing them about research advances and new research avenues.
Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study
